We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Hormone therapy — brand
Estradiol transdermal patch (twice-weekly, smallest)
The smallest FDA-approved estradiol patch — twice-weekly delivery in a fingertip-sized patch.
Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-07-03
Minivelle is a brand-name transdermal estradiol patch — currently the smallest FDA-approved estradiol patch in the U.S., about the size of a small bandage. It delivers bioidentical 17β-estradiol continuously through the skin and is changed twice weekly (every 3–4 days).
Available doses: 0.025, 0.0375, 0.05, 0.075, and 0.1 mg/day. Manufactured by Noven Pharmaceuticals, approved by the FDA in 2012 specifically as the smallest matrix-design estrogen patch on the market. Women with a uterus need a progestogen alongside Minivelle to protect the endometrial lining.
A matrix patch delivers steady bioidentical estradiol through the skin, bypassing the liver entirely. This transdermal route avoids the first-pass metabolism that drives the elevated VTE and stroke risk seen with oral estrogens — the major safety reason NAMS, ACOG, and the Endocrine Society now prefer transdermal delivery in most candidates.
Pharmacokinetically Minivelle behaves like every other matrix estradiol patch (Vivelle-Dot, Climara, Alora, generic estradiol patch) at matched daily doses. The difference is form factor: ~40% smaller patch surface area than Vivelle-Dot, less visible under clothing, and lower rate of adhesive-related skin reactions in head-to-head tolerability data.
Minivelle is an FDA-approved brand-name product. Many Kindr patients use compounded alternatives prepared by a state-licensed 503A pharmacy when a custom dose, custom combination, or different delivery form is clinically preferable. Both pathways are available through Kindr — your provider will recommend based on your individual needs.
Minivelle is roughly the size of a small bandage — about 40% smaller than Vivelle-Dot and significantly smaller than Climara or older patches like Estraderm. It is currently the smallest FDA-approved estradiol patch on the U.S. market.
Twice weekly — every 3 to 4 days. A common schedule is Sunday/Wednesday or Monday/Thursday. Climara is a weekly patch (once every 7 days); Minivelle is the twice-weekly option.
Retail cash price runs roughly $150–$250 per month depending on dose and pharmacy. Generic estradiol transdermal patches (which are bioequivalent) typically cost $30–$80. With kindr Health, your $89/month membership includes most HRT medications — including transdermal estradiol — with free shipping.
Generic estradiol transdermal patches are widely available and bioequivalent to brand-name patches at matched doses. Whether a specific "Minivelle-equivalent" generic (same small form factor) is in stock depends on pharmacy supply — many generics are closer in size to Vivelle-Dot. Your kindr clinician will prescribe the most cost-effective bioequivalent form.
Both are matrix transdermal estradiol patches changed twice weekly. Minivelle is the smaller, newer (2012) version from the same manufacturer (Noven). Doses and bioavailability are equivalent at matched mg/day. Choose Minivelle for the smallest profile; Vivelle-Dot remains a clinically equivalent alternative if supply or cost favors it.
Climara is changed once per week; Minivelle twice. Climara is larger (~5x the surface area). For women who prefer weekly application and tolerate a larger patch, Climara wins on convenience. For women who want the smallest, least visible patch and can do twice-weekly application, Minivelle wins on cosmesis and skin tolerability.
Lower abdomen or upper buttock are the FDA-approved sites. Rotate sites with each patch change (do not reapply to the exact same spot for at least one week). Do not apply to breasts. Press firmly for 10 seconds after application; the patch is shower-, exercise-, and swim-safe.
Yes, if you have a uterus. Unopposed estrogen increases endometrial cancer risk. Standard regimens pair Minivelle with oral micronized progesterone (100–200 mg nightly) either continuously or cyclically. Women who have had a hysterectomy can use Minivelle alone.
Yes. kindr Health clinicians are licensed in all 50 states and prescribe Minivelle (and bioequivalent generic estradiol patches) via telehealth when clinically appropriate. The 10-minute online intake leads to a clinician decision within 24 hours and medication ships in 3–5 business days.
Vasomotor symptoms (hot flashes, night sweats) typically improve within 2–4 weeks, with full benefit by 8–12 weeks. Sleep and mood improvements usually follow the vasomotor response. Vaginal symptoms may need longer or local vaginal estrogen alongside.
Coverage varies widely. Many plans cover brand-name Minivelle with prior authorization; bioequivalent generic estradiol patches are almost universally covered. kindr Health does not bill insurance — membership is $89/mo with most HRT included and HSA/FSA eligible.
Yes. The patch is designed to stay on through showers, swimming, and exercise. Avoid hot tubs or saunas with the patch applied (heat may increase absorption rate). If a patch falls off mid-cycle, apply a new one and continue the original schedule.
Medically reviewed by Kindr Health Clinical Team
Kindr Health Inc. — Editorial & Clinical Team (physician-supervised)
NPI 1609792902 · Last reviewed: July 3, 2026
Hormone therapy
Micronized Progesterone →Hormone therapy
Testosterone (low-dose, female-physiologic) →Hormone therapy
Semaglutide →GLP-1 weight care
This page is educational and is not a substitute for a clinical evaluation. Whether any medication is appropriate for you depends on your full medical history. Kindr providers make individualized prescribing decisions during a clinical visit.